pains, primarily in ankles and knees, presented at rheumatology with fever and swelling of the right elbow.
Blood sample result included an abnormal lipid metabolism with hypercholesterolemia (total cholesterol 248 mg/dl, nl range < 190 mg/dl; LDL 136 mg/dl, nl range < 115 mg/dl; triglycerides 335 mg/dl, nl range 150 mg/dl), elevated C-reactive protein (14,9 mg/l, nl range < 5 mg/l), elevated white blood cell count (13,8 × 10 3 /mm 3 , nl range 3,6-9,6 × 10 involvement of the lungs included a thickening of the interlobular septa; in the abdomen perinephric stranding, an atypical sign of retroperitoneal fibrosis, was present (Fig. 4) . All visceral and skeletal lesions were hypermetabolic (Fig. 5) .
Discussion ECD is a rare form of nonLangerhans' cell histiocytosis affecting middle-aged adults (mean age of toms depend on the type of affected extra-skeletal tissue. In order of frequency of occurrence these comprehend retroperitoneal fibrosis, diabetes insipidus, exophalmia, xanthomas, neurologic signs (ataxia), dyspnea, kidney failure, hypopituitarism, liver failure. Of all cases 70-80% have skeletal involvement and more than 50% have visceral involvement (4) .
Radiological hallmarks (X-ray/CT) include symmetric heterogeneous 53 years) without gender predisposition (3). The condition seems nonfamilial and no predisposing factors are defined (2) . The precise origin of this disease is not yet fully understood; currently it has not been classified as cancer, neither as an infectious or autoimmune disease.
Diagnosis of ECD remains challenging. Mild permanent juxtaarticular bone pain is the most frequent symptom and mainly affects the lower limbs. Other symp- A B osteosclerosis of the diaphysis and metaphysis of the long bones with epiphyseal sparing (4, 5) . Bone scintigraphy shows a corresponding symmetric increased tracer uptake in the diaphysis and metaphysis of primarily the long bones (6, 7) . MRI depicts a replacement of the normal fatty bone marrow by a heterogeneous high intensity signal infiltrate on T1 sequence after intravenous injection of gadolinium, sparing the epiphysis (5).
Biopsy reveals a diffuse infiltration of bone and soft tissues by foamy histiocytes, further characterized by immunohistochemistry as non-Langerhans' cell (S 100 -and CD 1a -) macrophages (CD 68 +) (3) .
As seen in our patient, blood samples often disclose an abnormal lipid metabolism, a moderate anaemia (related to the severity of the destruction of normal bone marrow, chronic inflammation and renal insufficiency), an increased sedimentation rate and C-reactive protein (signs of active inflammation).
Because of the rarity of this disease, no clinical trials have been conducted and treatment plans are mainly based on anecdotal experience. Treatment options are not curative but attempt to control the disease extension and include chirurgi-cal debulking, systemic steroids, interferon alpha, various cytotoxic agents, radiation therapy and stem cell transplantation.
18F FDG PET/CT not only allows accurate staging of the disease (visceral and skeletal involvement), it is also an extremely useful tool to monitor treatment efficiency (8) .
The prognosis of patients with ECD is related to the extent of disease at presentation and especially the severity of visceral involvement. Most patients with extra-skeletal disease die within 3 years after diagnosis due to congestive heart failure, lung fibrosis or renal insufficiency (4).
Conclusion
ECD is a rare form of nonLangerhans' cell histiocytosis, which still remains frequently unrecognized. The typical symmetric long bone involvement and the FDGavidity of these osteoblastic lesions should however lead to the correct diagnosis in the era of hybrid imaging with 99m Tc MDP bone SPECT/CT or 18 F FDG PET/CT.
